Immunic
IMUX
IMUX
58 hedge funds and large institutions have $81.3M invested in Immunic in 2018 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 14 closing their positions.
Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
16
Reduced
16
Closed
14
Calls
$114K
Puts
$830K
Net Calls
-$716K
Net Calls Change
-$276K
Top Buyers
| 1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$3.82M |
| 2 |
2
Millennium Management
New York
|
$2.82M |
| 3 |
3
Goldman Sachs
New York
|
$1.31M |
| 4 |
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.32M |
| 5 |
AG
5
Artal Group
Luxembourg
|
$6.8M |
